1478833

Orlistat Related Compound C

United States Pharmacopeia (USP) Reference Standard

• Sinónimos: Triphenylphosphine oxide, Ph₃PO, TPPO, Triphenyl phosphorus oxide, Triphenylphosphine monoxide
• Fórmula lineal: (C₆H₅)₃PO
• Número CAS: 791-28-6
• Peso molecular: 278.28
• UNSPSC Code: 41116107
• NACRES: NA.24
• PubChem Substance ID: 329750619
• MDL number: MFCD00002080
• Beilstein/REAXYS Number: 745854
• eCl@ss: 25140904

Propiedades

• grade: pharmaceutical primary standard
• agency: USP
• API family: orlistat
• form: crystalline
• manufacturer/tradename: USP
• mp: 150-157 °C (lit.)
• application(s): pharmaceutical; pharmaceutical (small molecule)
• format: neat
• SMILES string: O=P(c1ccccc1)(c2ccccc2)c3ccccc3
• InChI: 1S/C18H15OP/c19-20(16-10-4-1-5-11-16,17-12-6-2-7-13-17)18-14-8-3-9-15-18/h1-15H
• InChI key: FIQMHBFVRAXMOP-UHFFFAOYSA-N

Descripción

General description

Find answers to frequently asked questions on USP products in USP FAQs.

Orlistat Related Compound C is a chemical impurity related to the active pharmaceutical ingredient Orlistat. It is a by-product that can be formed during the synthesis of Orlistat and is closely monitored in biologic formulations. The presence of this compound is typically controlled, as it may impact the safety, efficacy, and regulatory compliance of the final product.

The United States Pharmacopeia (USP) provides quality standards for biologics to ensure their safety, efficacy, and quality throughout the manufacturing process. These standards assist manufacturers in adhering to regulatory requirements and help safeguard public health by reducing risks associated with biologics.

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Orlistat Related Compound C USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. Also, for use with USP monographs such as:

• Latanoprost
• Orlistat

Analysis Note

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

Other Notes

Sales restrictions may apply.

This product is part of USP Biologics Program.

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pha

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Información de seguridad

• Pictogramas: GHS07
• Palabra de advertencia: Warning
• Códigos de peligro: H302,H412
• Indicaciones de precaución: P264 - P270 - P273 - P301 + P312 - P501
• Hazard Classifications: Acute Tox. 4 Oral - Aquatic Chronic 3
• Clase de almacenamiento: 11 - Combustible Solids
• WGK: WGK 2
• Punto de inflamación (°F): Not applicable
• Punto de inflamación (°C): Not applicable